Doctor-Tailored stent graft aims to tame deadly aortic aneurysms
NCT ID NCT02989948
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 31 times
Summary
This study tests a stent graft that doctors modify to fit each patient's unique aneurysm in the chest and abdomen. The goal is to see if this less invasive approach is as safe and effective as traditional open surgery. About 80 people aged 50 and older with large aneurysms will take part. Success is measured by survival, complications, and whether the aneurysm is sealed off at one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC ANEURYSM, THORACOABDOMINAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Dartmouth-Hitchcock Medical Center
ACTIVE_NOT_RECRUITINGLebanon, New Hampshire, 03766, United States
-
Yale New Haven Hospital
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
physician-modified aortic stent graft
What this could lead to
If successful, this could offer a less invasive treatment option for complex aortic aneurysms, potentially reducing recovery time and complications compared to open surgery.
What could go wrong
This is a single-arm study with only 80 participants, so results may not apply to all patients. The graft is modified by the physician, which could lead to variability in outcomes, and there are risks like rupture or device failure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.